FindTrial
Sign In

Effect of 2 medicines in electric shock therapy

Clinical efficacy of Propofol and Etomidate in Electroconvulsive therapy - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056304
Enrollment
60
Registered
2023-08-09
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F29- Unspecified psychosis not due to asubstance or known physiological condition

Interventions

Intervention1: NIL: NIL

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age group 18-60 years 2. Patients of both SEX 3. ASA Grade 1&2

Exclusion criteria

Exclusion criteria: Patient refusal Patients aged below 18 and above 60 years Patients with risk of aspiration Cardiovascular disease Neuromuscular problems Major sicknesses like Bronchial asthma and Tuberculosis Patients with implants Pregnancy Drug allergy

Design outcomes

Primary

MeasureTime frame
To evaluate the effects of propofol & etomidate in attenuation of the stress response, induction time, seizure duration, & recovery time during ECT.Timepoint: Immediately after induction till 10 min after procedure—

Secondary

MeasureTime frame
To observe the occurance of any side effects & complications of ECT. To observe the occurrence of any side effects and complications related to propofol and etomidate. Timepoint: Immediately after induction till 10 min after procedure—

Countries

India

Contacts

Public ContactDr Rajkumar Ahirwal

Gandhi medical college

yashwantdhawalegmc@gmail.com9425667373

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026